Erratum to: Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype

Erratum to: J Inherit Metab Dis (2015) 38:279–286 DOI 10.1007/s10545-014-9747-y The original version of this article unfortunately contained a mistake. The reference by Whited is incomplete. The corrected reference is: Whited K, Baile MG, Currier P, Claypool SM (2013) Seven functional classes of Barth syndrome mutation. Human Molecular Genetics 22:483–492.

• Publication year

  2015

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2015-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10545-015-9891-zPMID 26373950PMCID 4969951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Barth syndrome

  2019cited by this paper
• Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype

  2014cited by this paper
• Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis

  2013cited by this paper
• Seven functional classes of Barth syndrome mutation.

  2013cited by this paper
• Natural history of Barth syndrome: a national cohort study of 22 patients

  2013cited by this paper
• A Novel Exonic Splicing Mutation in the TAZ (G4.5) Gene in a Case with Atypical Barth Syndrome.

  2013cited by this paper
• The Barth Syndrome Registry: Distinguishing disease characteristics and growth data from a longitudinal study

  2012cited by this paper
• Primer3—new capabilities and interfaces

  2012cited by this paper
• Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome*

  2010cited by this paper
• The 3-methylglutaconic acidurias: what’s new?

  2010cited by this paper
• Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth

  2010cited by this paper
• Dysmorphology of Barth syndrome

  2009cited by this paper
• Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.

  2009cited by this paper
• UvA-DARE ( Digital Academic Repository ) A mass spectrometric approach to investigate cardiolipin metabolism in Barth syndrome

  2007cited by this paper
• New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome.

  2007cited by this paper
• Enhancements and modifications of primer design program Primer3

  2007cited by this paper
• A Drosophila model of Barth syndrome.

  2006cited by this paper
• Cardiac and Clinical Phenotype in Barth Syndrome

  2006cited by this paper
• Barth syndrome without 3‐methylglutaconic aciduria

  2004cited by this paper
• Deficiency of tetralinoleoyl‐cardiolipin in Barth syndrome

  2002cited by this paper
• Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.

  2002cited by this paper
• Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome.

  2000cited by this paper
• A novel X-linked gene, G4.5. is responsible for Barth syndrome

  1996cited by this paper
• X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.

  1991cited by this paper

• No citing papers are available for this paper.